Teva marketing three-tranche euro-denominated M&A bond

LONDON, July 20 (IFR) - Teva Pharmaceutical has started

marketing an expected 4bn multi-tranche euro bond issue to help

fund its US$40.5bn acquisition of Actavis Generics, according to

a lead bank.

Read more